Implications of Frailty in COVID-19
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved..
As the global coronavirus disease-19 (COVID-19) pandemic caused by severe acute respiratory distress syndrome coronavirus 2 continues to cause higher mortality and hospitalization rates among older adults, strategies such as frailty screening have been suggested for resource allocation and clinical management. Frailty is a physiologic condition characterized by a decreased reserve to stressors and is associated with disability, hospitalization, and death. Measuring frailty can be a useful tool to determine the risk and prognosis of COVID-19 patients in the acute setting, and to provide higher quality of care for vulnerable individuals in the outpatient setting. A literature review was conducted to examine current research regarding frailty and COVID-19. Frailty can inform holistic care of COVID-19 patients, and further investigation is needed to elucidate how measuring frailty should guide treatment and prevention of COVID-19.
| Errataetall: |
CommentIn: Cardiol Rev. 2021 Nov-Dec 01;29(6):281-282. - PMID 34380945 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
|---|---|
| Enthalten in: |
Cardiology in review - 29(2021), 6 vom: 01. Nov., Seite 285-288 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Lee, Curtis [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 11.10.2021 Date Revised 03.09.2023 published: Print CommentIn: Cardiol Rev. 2021 Nov-Dec 01;29(6):281-282. - PMID 34380945 Citation Status MEDLINE |
|---|
| doi: |
10.1097/CRD.0000000000000409 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM328371408 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM328371408 | ||
| 003 | DE-627 | ||
| 005 | 20231225202809.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/CRD.0000000000000409 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1094.xml |
| 035 | |a (DE-627)NLM328371408 | ||
| 035 | |a (NLM)34292183 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Lee, Curtis |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Implications of Frailty in COVID-19 |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.10.2021 | ||
| 500 | |a Date Revised 03.09.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentIn: Cardiol Rev. 2021 Nov-Dec 01;29(6):281-282. - PMID 34380945 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved. | ||
| 520 | |a As the global coronavirus disease-19 (COVID-19) pandemic caused by severe acute respiratory distress syndrome coronavirus 2 continues to cause higher mortality and hospitalization rates among older adults, strategies such as frailty screening have been suggested for resource allocation and clinical management. Frailty is a physiologic condition characterized by a decreased reserve to stressors and is associated with disability, hospitalization, and death. Measuring frailty can be a useful tool to determine the risk and prognosis of COVID-19 patients in the acute setting, and to provide higher quality of care for vulnerable individuals in the outpatient setting. A literature review was conducted to examine current research regarding frailty and COVID-19. Frailty can inform holistic care of COVID-19 patients, and further investigation is needed to elucidate how measuring frailty should guide treatment and prevention of COVID-19 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 700 | 1 | |a Frishman, William H |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cardiology in review |d 1997 |g 29(2021), 6 vom: 01. Nov., Seite 285-288 |w (DE-627)NLM09257050X |x 1538-4683 |7 nnns |
| 773 | 1 | 8 | |g volume:29 |g year:2021 |g number:6 |g day:01 |g month:11 |g pages:285-288 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1097/CRD.0000000000000409 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 29 |j 2021 |e 6 |b 01 |c 11 |h 285-288 | ||